Novartis AG will divest its nicotine replacement patch Habitrol, as mandated by the Federal Trade Commission, to go ahead with its consumer-health merger with GlaxoSmithKline. As Novartis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback